Closed shegocaga closed 11 months ago
The data of this study includes singular mAb's (sotrovimab), combination mAb's (imdevimab/casirivimab and cilgavimab/tixagevimab), and combination anti-protease (nirmatrelvir/ritonavir) and tests these treatments' neutralization activity at multiple time-points after administration. I am not sure I added these data correctly, especially around the handling of rx_name
s and dates within bruel23-prx.csv
.
@shegocaga you don't need to add the -mab.csv file, because all the treatment were plasma.
Bruel23 - 10.1101/2023.05.25.23290512 #926